HON Form 4: 580 RSUs converted; Rose Lee resigns from board
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Honeywell International (HON) filed a Form 4 disclosing a derivative equity change tied to its spinoff of Solstice Advanced Materials Inc. On October 30, 2025, Director Rose Lee had 580 Restricted Stock Units converted into a Solstice Advanced Materials award of equivalent value. The filing states the vesting terms are unchanged and all units will vest on April 15, 2026.
Following the transaction, the number of derivative securities beneficially owned was reported as 0, with ownership listed as direct. The filing also notes that Rose Lee resigned as a Director of Honeywell as of October 30, 2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Restricted Stock Units | 580 | $0.00 | $0.00 |
Footnotes (2)
- F1. Instrument converts to common stock on a one-for-one basis.
- F2. The Restricted Stock Units including all accrued dividends were converted to a Solstice Advanced Materials Inc. award of equivalent value on October 30, 2025. The vesting remains unchanged and all units will vest on April 15, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HON disclose in this Form 4?
What are the vesting terms after the RSU conversion for HON?
Did the reporting person remain a director of Honeywell (HON)?
How many derivative securities were held after the transaction?
What was the nature of the security in the HON Form 4?
What corporate action is referenced in the HON filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.